
zzso cancer zzso is the fourth leading cause of cancer mortality among women in Europe and the United zzso Its early detection is difficult due to the lack of specificity of clinical zzso Unfortunately, late diagnosis is a major contributor to the poor survival rates for zzso which can be attributed to the lack of specific sets of zzso Aside from patients sharing a strong family history of zzso and breast cancer, including the zzso and zzso tumor zzso genes zzso the most used zzso is the zzso 125 zzso zzso has a sensitivity of zzso and a specificity of zzso in zzso cancer zzso III or zzso However, its sensitivity is zzso in stage I cancer, as its increase is linked to several zzso phenomena and benign zzso zzso is particularly useful for zzso population diagnosis and to assess response to zzso It is clear that alone, zzso is inadequate as a zzso for zzso zzso There is an zzso need to identify additional zzso Novel and more sensitive zzso strategies such as zzso mass zzso imaging studies are well suited to identify better markers for both diagnosis and zzso In the present review, we will focus on such zzso strategies in regards to zzso signaling zzso zzso development and escape from the immune zzso 

